Knowledge Center
Webinar / Nov 19, 2018
Webinar - Amorphous Solid Dispersions: Increasing Solubility From API to Tablet
Source:
Webinar
![amorphous solid dispersions solubility API table | ËÄÉ«AV](/sites/default/files/styles/half_width_scaled/public/assets/images/webinar_asds_from_api_to_tablet_hovione.png?itok=19_21Ovv)
Speakers |
---|
João Henriques - Team Leader |
Paulo Lino - Scientist |
Ìý
Up to 90% of the drugs in the pharmaceutical pipeline are classified as poorly soluble,Ìýaccording to the Biopharmaceutical Classification System. Amorphous solid dispersions have emerged as one of the preferred methods to increase aqueous solubility of drugs.
This webinar will focus on several aspects of the formulation screening of amorphous solid dispersions, for both the drug product intermediate and the final drug product.
Ìý
Key Learning Objectives:
- Overview of amorphous solid dispersion as an enabling technique in the pharmaceutical industry
- Screening methodologies for amorphous solid dispersions
- Drug product formulation of amorphous solid dispersions
Watch On-Demand Webinar!
(Restricted Access)
Also in the Knowledge Center
/ Jan 01, 2013
Process for the preparation of disubstituted triiodoanilines by iodination of 3,5-disubstituted anilines
Read more
Scientific Article
/ Jan 01, 2013
Manufacture of a triiodinated contrast agent via a new compound of (S)-5-(2-acetoxypropanamido)-2,4,6-triiodoisophthalic acid
Read more
Scientific Article
Scientific Article